Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Men or women between 15 and 29 years old who have been diagnosed with a hereditary nerve condition called hereditary sensorimotor polyneuropathy (HSPN), of any type, and who live in the community (for the patient group).
- Healthy men or women between 15 and 29 years old who live in the community (for the comparison group).
- People who can still move their ankle up and down, at least to a flat (neutral) position, which allows them to take part in strength exercises.
Who may not be able to join:
- People who have bone, joint, or movement problems that would make it unsafe to do resistance (strength) exercises — for example, having had an ankle fusion surgery.
- People who currently use certain dietary or nutritional supplements that could affect muscle function, such as leucine, glutamine, casein, whey protein, fatty acids, or creatine, among others.
- People who have a long-term (chronic) illness that is not being treated or is not well managed, or who have an intellectual disability.
- People who have a history of surgery (confirm with trial site for further details on what types of surgery this includes).
- People who have taken part in a structured strength or resistance exercise training program in the past 6 months.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +56950166328
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Changes in muscle echogenicity as marker of muscle quality; Changes in muscle thickness as marker of muscle quality
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.